Accelovance: Recently merged CROs Accelovance and Linical rebrand, name new CEO
Accelovance and Linical merged in March of this year to create a global midsized CRO for which âfuture possibilities are endless,â says newly appointed CEO.
Read full article »
Accelovance is a provider of digital contract research solutions for pharmaceutical, biotechnology and medical device companies.
Read more